Literature DB >> 11465926

Motoneuron cell death and neurotrophic factors: basic models for development of new therapeutic strategies in ALS.

M Beck1, C Karch, S Wiese, M Sendtner.   

Abstract

Motoneurons are generated in excess during embryonic development of higher vertebrates. In the lumbar spinal cord of the developing rat, about 6000 motoneurons are present at embryonic day 14. These neurons grow out axons which make contact with their target tissue, the skeletal muscle. About 50% of the motoneurons are lost during a critical period from embryonic day 14 until postnatal day 3. This process, which is called physiological motoneuron cell death, has been the focus of research aiming at the identification of neurotrophic factors which regulate motoneuron survival during this developmental period. Motoneuron cell death can also be observed in vitro when the motoneurons are isolated from the embryonic avian or rodent spinal cord. These isolated motoneurons and other types of primary neurons have been a useful tool for studying basic mechanisms underlying neuronal degeneration during development and under pathophysiological conditions in neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS). Accumulating evidence from such studies suggests that some specific requirements of motoneurons for survival and proper function may change during development. These findings might be relevant for understanding the pathophysiological processes underlying ALS and thus could contribute to the development of new therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465926

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  6 in total

1.  High-efficiency transfection of cultured primary motor neurons to study protein localization, trafficking, and function.

Authors:  Claudia Fallini; Gary J Bassell; Wilfried Rossoll
Journal:  Mol Neurodegener       Date:  2010-04-21       Impact factor: 14.195

2.  Preserved expression of fibroblast growth factor (FGF)-2 and FGF receptor 1 in brain and spinal cord of amyotrophic lateral sclerosis patients.

Authors:  Susanne Petri; Klaus Krampfl; Kerstin Kuhlemann; Reinhard Dengler; Claudia Grothe
Journal:  Histochem Cell Biol       Date:  2008-12-19       Impact factor: 4.304

3.  Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS.

Authors:  Angelo C Lepore; Christine Haenggeli; Mehdi Gasmi; Kathie M Bishop; Raymond T Bartus; Nicholas J Maragakis; Jeffrey D Rothstein
Journal:  Brain Res       Date:  2007-09-22       Impact factor: 3.252

4.  Neurotrophic requirements of human motor neurons defined using amplified and purified stem cell-derived cultures.

Authors:  Nuno Jorge Lamas; Bethany Johnson-Kerner; Laurent Roybon; Yoon A Kim; Alejandro Garcia-Diaz; Hynek Wichterle; Christopher E Henderson
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

5.  A conditioning lesion provides selective protection in a rat model of Amyotrophic Lateral Sclerosis.

Authors:  Colin K Franz; Eric T Quach; Christina A Krudy; Thais Federici; Michele A Kliem; Brooke R Snyder; Bethwel Raore; Nicholas M Boulis
Journal:  PLoS One       Date:  2009-10-06       Impact factor: 3.240

6.  Limitations and Challenges in Modeling Diseases Involving Spinal Motor Neuron Degeneration in Vitro.

Authors:  Monica Bucchia; Samantha J Merwin; Diane B Re; Shingo Kariya
Journal:  Front Cell Neurosci       Date:  2018-03-06       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.